Santhera Pharmaceuticals Holding AG (SPHDF)
USD 17.01
(5.0%)
USD 17.01
(5.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 119.1 Million USD | 3239.17% |
| 2022 | 3.53 Million USD | 153.41% |
| 2021 | -6.62 Million USD | -1322.96% |
| 2020 | 541.88 Thousand USD | -99.23% |
| 2019 | 70.42 Million USD | 164.45% |
| 2018 | 26.63 Million USD | 40.31% |
| 2017 | 18.97 Million USD | 29.25% |
| 2016 | 14.68 Million USD | 417.59% |
| 2015 | 2.83 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.95 Million USD | 159.37% |
| 2024 Q1 | 4.93 Million USD | -95.75% |
| 2023 Q2 | 1.9 Million USD | 73.22% |
| 2023 FY | 118.18 Million USD | 3239.17% |
| 2023 Q1 | 1.09 Million USD | 226.27% |
| 2023 Q3 | 53.62 Million USD | 2716.26% |
| 2023 Q4 | 116.16 Million USD | 116.64% |
| 2022 Q2 | 4.26 Million USD | 0.0% |
| 2022 Q4 | -870.52 Thousand USD | -247.75% |
| 2022 FY | 3.53 Million USD | 153.41% |
| 2022 Q3 | -250.33 Thousand USD | -105.87% |
| 2021 Q2 | 2.25 Million USD | 0.0% |
| 2021 FY | -6.62 Million USD | -1322.96% |
| 2021 Q4 | -8.91 Million USD | 0.0% |
| 2020 Q2 | 5.09 Million USD | 0.0% |
| 2020 FY | 541.88 Thousand USD | -99.23% |
| 2020 Q4 | -4.91 Million USD | 0.0% |
| 2019 FY | 70.42 Million USD | 164.45% |
| 2019 Q4 | 55.03 Million USD | 0.0% |
| 2019 Q2 | 15.27 Million USD | 0.0% |
| 2018 FY | 26.63 Million USD | 40.31% |
| 2017 FY | 18.97 Million USD | 29.25% |
| 2016 FY | 14.68 Million USD | 417.59% |
| 2015 FY | 2.83 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 4883559.451% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -917.492% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 37378.55% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 561.693% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 246909.043% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 95960.457% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -694.103% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -3839602.643% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | -1116.128% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -181112.841% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 348877.675% |
| Mesoblast Limited | -35.16 Million USD | 438.682% |
| Marizyme, Inc. | 457.7 Thousand USD | -25922.953% |
| Genus plc | 178.7 Million USD | 33.348% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 45.886% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -191311.269% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -28938.942% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 1082896.145% |
| ContraFect Corporation | -154 Thousand USD | 77442.582% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 238315.152% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -155066.785% |
| IMV Inc. | -962.29 Thousand USD | 12477.411% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 30837.36% |
| MultiCell Technologies, Inc. | 49.32 USD | -241499445.823% |
| ONE Bio Corp. | 20.12 Million USD | -491.826% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -195.809% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -243473.775% |
| Q BioMed Inc. | -8988.00 USD | 1325284.424% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -321.545% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 772322.355% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -168.515% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 10533.646% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -170053.68% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 2405341.842% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -84674.075% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 122242.825% |
| GB Sciences, Inc. | -624.00 USD | 19087852.564% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 138552.104% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 98.425% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 57263357.692% |
| Enzolytics Inc. | 30.7 Thousand USD | -387771.486% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -24588.936% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 89.255% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 23249.711% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -19192.3% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 70.918% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 1345036.495% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 142150.085% |
| Kadimastem Ltd | -630.13 Thousand USD | 19001.824% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -11955.655% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -1139.284% |
| BioStem Technologies, Inc. | 15.42 Million USD | -672.18% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 1006501.149% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -67360.113% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -67360.113% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -8676.347% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 410815.779% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -26365.821% |
| SYBLEU INC | 11.69 Thousand USD | -1018261.628% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -2484.8% |
| Bioxytran, Inc. | -8285.00 USD | 1437729.161% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 32032.326% |
| Neutra Corp. | 14.33 Thousand USD | -830786.474% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 145353.141% |
| PureTech Health plc | -1.6 Million USD | 7530.292% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 11996.054% |
| IXICO plc | 3.27 Million USD | -3542.434% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 17262.475% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 6750.339% |
| CSL Limited | 7.7 Billion USD | 98.454% |
| Cellectis S.A. | 18 Thousand USD | -661608.756% |